Stratification and Management of Cardiovascular Risk among Patients with Psoriasis

Older patients belong to the group with increased CVD risk, and one of the pillars of modern medicine is the stratification of risk and its reduction. Hence, physicians must approach the patient holistically and consider the multitude of factors that increase that risk. Recent reports suggest that, in addition to the classic cardiovascular risk factors, there is a group of lesser-known factors that also increases the incidence of CVD. One of them is psoriasis. This disease, known primarily for its cutaneous manifestation, actually impacts the whole body due to systemic inflammation. The challenge for physicians is to incorporate these new risk factors into the standard management of patients with psoriasis and to adjust treatment. Our work aims to analyse not only the association of psoriasis with increased CVD risk, but also what therapeutic options are available. This work also seeks to outline the actual risk in patients with psoriasis, which is higher than in the general population, as well as to highlight the problem that there are no tools that can unambiguously determine it.